Nitsch, Roberto
Institute of Molecular Biotechnology · Austrian Academy of Sciences · AstraZeneca (Sweden)
5 papers on CoChatORCID 0000-0001-8766-6267
Most cited papers
- Verified
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
Paolino, M., Choidas, A., Wallner, S., Pranjic, B., Uribesalgo, I., Loeser, S., Jamieson, A. M., Langdon, W. Y., Ikeda, F., Fededa, J. P., et al. (2014) · Nature
Immune Cell Function and InteractionImmune cells in cancer
Cited by 456
- Verified
The paired domain-containing factor Pax8 and the homeodomain-containing factor TTF-1 directly interact and synergistically activate transcription
Di Palma, T., Nitsch, R., Mascia, A., Nitsch, L., Di Lauro, R., & Zannini, M. (2003) · Journal of Biological Chemistry
Thyroid Disorders and TreatmentsDevelopmental Biology and Gene Regulation
Cited by 138
- Verified
The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate
Tortola, L., Nitsch, R., Bertrand, M. J. M., Kogler, M., Redouane, Y., Kozieradzki, I., Uribesalgo, I., Fennell, L. M., Daugaard, M., Klug, H., et al. (2016) · Cell Reports
Cell death mechanisms and regulationNF-κB Signaling Pathways
Cited by 64
- Verified
Pendrin is a novel in vivo downstream target gene of the TTF-1/Nkx-2.1 homeodomain transcription factor in differentiated thyroid cells
Dentice, M., Luongo, C., Elefante, A., Ambrosio, R., Salzano, S., Zannini, M., Nitsch, R., Di Lauro, R., Rossi, G., Fenzi, G., et al. (2005) · Molecular and Cellular Biology
Thyroid Disorders and TreatmentsDevelopmental Biology and Gene Regulation
Cited by 48
- Verified
Functional inactivation of the transcription factor Pax8 through oligomerization chain reaction
D’Andrea, B., Iacone, R., Di Palma, T., Nitsch, R., Baratta, M. G., Nitsch, L., Di Lauro, R., & Zannini, M. (2006) · Molecular Endocrinology
Thyroid Disorders and TreatmentsThyroid Cancer Diagnosis and Treatment
Cited by 29
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free